What is Phoenix Pharmaceuticals?
Phoenix Pharmaceuticals, Inc. is a bio-research firm with over three decades of experience, dedicated to advancing scientific studies. The company offers a diverse range of products, including labeled peptides, magnetic beads, polyclonal antibodies, and various assay kit supplies. These offerings support critical research in areas such as obesity, cancer, and diabetes. Phoenix Pharmaceuticals emphasizes quality and customization, striving to meet the precise requirements of researchers globally.
How much funding has Phoenix Pharmaceuticals raised?
Phoenix Pharmaceuticals has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Phoenix Pharmaceuticals
PPP
Public-Private Partnership
What's next for Phoenix Pharmaceuticals?
The company's large-scale late-stage funding context suggests a strategic pivot towards scaling operations and potentially expanding its market reach. This substantial capital injection is likely to fuel further product development, enhance manufacturing capabilities, and bolster its research and development pipeline. Phoenix Pharmaceuticals is well-positioned to leverage this financing to solidify its standing in the competitive bio-research market and accelerate its mission to support scientific discovery.
See full Phoenix Pharmaceuticals company page
